Schedule 13D ownership disclosure
Avinger Inc Ordinary Shares
Common Stock, par value $0.001 per share · CUSIP: 053734877
Event date: 2024-03-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Zylox-Tonbridge Medical Technology Co., Ltd.Reported CIK 0002015487
Shares: 1,981,655.00 · Class: 49.9%
- Zhao Jonathon ZhongReported CIK 0002015387
Shares: 1,981,655.00 · Class: 49.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002015487-24-000003
- Form type
- SCHEDULE 13D/A
- Filer
- Avinger Inc
- CIK
- CIK 1506928
- Filed
- Jun 03, 2024
- Reporting period
- Mar 05, 2024
- Description
- Schedule 13D beneficial ownership